本拉利祖马布诱导的喘缓解:不同工具和值对定义良好的喘控制的影响
Marek Lommatzsch1, Henrik Watz2, Thorsten Grund3
1Department of Pneumology, University of Rostock, Rostock, Germany.
Respiration; international review of thoracic diseases
|September 8, 2025
概括
在接受本拉利祖马布治疗的严重喘患者中,可以实现临床缓解. 然而,缓解率在很大程度上取决于所选择的喘控制定义,强调在严重喘管理中需要标准化标准.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 现实世界的证据.
背景情况:
- 目前对喘的临床缓解 (CR) 定义使用各种工具和值来评估喘控制.
- 这些不同的定义对重症喘患者CR率的影响尚不清楚.
研究的目的:
- 评估不同喘控制措施和值对使用本拉利祖马布治疗的重症喘患者CR率的影响.
- 评估在现实世界严重喘队列中实现四组分临床缓解 (4-CR) 的可行性.
主要方法:
- 分析了244名患有严重酸性喘 (SEA) 的患者的现实数据,这些患者接受了本拉利祖马布治疗.
- 定义为 4-CR 缺乏恶化,全身类固醇,稳定的肺功能和至少12个月的良好喘控制.
- 使用喘控制问卷 (ACQ) 和喘控制测试 (ACT) 检查的CR率.
主要成果:
- 在12个月后,4-CR率从42.7% (ACQ-6 ≤1.5) 到21.5% (ACT ≥23) 不同.
- 在24个月后,4-CR率从39.2% (ACQ-6 ≤1.5) 到17.6% (ACT ≥23) 之间.
- 在使用ACQ-6 ≤1.5时,CR率几乎是使用ACT ≥23.5时的两倍.
结论:
- 在大量接受本拉利祖马布在现实环境中的严重喘患者中,可以实现临床缓解.
- 控制喘的定义极大地影响了CR率.
- 标准化喘控制指标对于在严重喘中进行一致的CR评估至关重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


